(Updated - October 29, 2020 6:09 AM EDT)

(updating comment)JPMorgan analyst Anupam Rama downgraded ChemoCentryx (NASDAQ: CCXI) from Overweight ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE